Van Den Neste, E
Schmitz, N
Mounier, N
Gill, D
Linch, D
Trneny, M
Milpied, N
Radford, J
Ketterer, N
Shpilberg, O
Dührsen, U
Ma, D
Brière, J
Thieblemont, C
Salles, G
Moskowitz, C H
Glass, B
Gisselbrecht, C
Article History
Received: 7 July 2015
Accepted: 31 July 2015
First Online: 14 September 2015
Competing interests
: CG: Roche—Research Funding. MT: Roche—Honoraria, Research Funding. JR: Roche—Consultancy. OS: Roche—Consultancy, Honoraria, Research Funding. UD: Roche Pharma—Honoraria, Research Funding. CHM: Genentech—Consultancy, Research Funding. BG: Roche—Honoraria, Research Funding. GS: Roche—Honoraria, research funding. The authors declare no conflict of interest.